![](https://netrf.org/wp-content/uploads/2019/07/thumbnail-e1563907188953.png)
Annual report shows progress in NET research.
June 2019 eUpdate: Annual report on progress, experimental targeted therapy shows promise, saying goodbye and hello to NETRF leaders.
The Neuroendocrine Tumor Research Foundation directs your individual donations to breakthrough scientific research. Since 2005, we have funded $37.6 million in research projects. The Neuroendocrine Research Foundation is a 501(c)(3) organization, so all donations are fully tax-deductible to the extent allowed by law. We are grateful to you for your generosity.
The Neuroendocrine Tumor Research Foundation directs your individual donations to breakthrough scientific research. Since 2005, we have funded $37.6 million in research projects. The Neuroendocrine Research Foundation is a 501(c)(3) organization, so all donations are fully tax-deductible to the extent allowed by law. We are grateful to you for your generosity.
The Neuroendocrine Tumor Research Foundation (NETRF) is the leading private funder of research into causes and treatments of neuroendocrine tumors (NETs) to improve and extend the lives of those living with NETs.
June 2019 eUpdate: Annual report on progress, experimental targeted therapy shows promise, saying goodbye and hello to NETRF leaders.
May 2019 eUpdate: NETRF seeks new grantees. Cell line initiative announced. Rocks for Hopes fundraiser.
April 2019 eUpdate: New info resources for patients and families. Eating to relieve NET symptoms. New info resources for patients and families. Eating to relieve NET symptoms.
March 2019 eUpdate: NET organoids attract attention. Taking a closer look at lung NETs. Stress and cancer.
January 2019 eUpdate: PRRT approval stands out in a year of progress in advancing knowledge of NETs.